Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

11.11
Delayed Data
As of Sep 03
 -0.29 / -2.54%
Today’s Change
9.16
Today|||52-Week Range
17.53
-28.32%
Year-to-Date

Today’s Trading

Previous close11.40
Today’s open11.34
Day’s range10.99 - 11.60
Volume1,248,202
Average volume (3 months)1,682,777
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-39.80%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio237.3
Price/Sales9.80
Price/Book41.17

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.02+0.26%
FGENFibroGen Inc-0.91-3.87%
EXELExelixis Inc-0.34-5.76%
LXRXLexicon Pharmaceutic...-0.55-4.35%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers